Drik LLC is a preclinical contract research organization (CRO) based in Oklahoma City, specializing in preclinical drug development for the pharmaceutical, cosmetic, and chemical industries. They offer a wide range of in vitro testing and animal studies, including in vivo testing and toxicology tests, to evaluate the safety and efficacy of new agents. Drik's niche service is in 3D Organotypic slice cultures, providing a reliable de-risk strategy for drug discovery.
With comprehensive processes and procedures in place for animal acclimation, dosing, observations, and pathology, Drik ensures the highest standards of animal welfare. Their team of experts is dedicated to providing customized solutions for drug development, safety pharmacology, and drug metabolism. Drik is committed to advancing the future of discovery through present safety testing.
Generated from the website